<html>
 <body>
  <div class="col-md-12" id="content" style="">
   <div class="hidden" data-drupal-messages-fallback="">
   </div>
   <div class="widget block" id="block-medsites-page-title">
    <h1>
     <span property="schema:name">
      Alcoholic Hepatitis
     </span>
    </h1>
   </div>
   <div class="widget block" id="block-medsites-content">
    <article about="/commodorecompendium/alcoholic-hepatitis" data-history-node-id="950" role="article" typeof="schema:WebPage">
     <div>
      <div class="field field--name-body field--type-text-with-summary field--label-hidden field__item" property="schema:text">
       <div class="WordSection1">
        <table class="TableGrid8" style="width:100.0%; border-collapse:collapse; border:none" width="100%">
         <table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th>0</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Alcoholic Hepatitis – Alex Wiles, Julie Cui</td>
    </tr>
  </tbody>
</table>
        </table>
        <p>
         <span style="page:WordSection1">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               Background
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                Acute onset of rapidly progressive jaundice in pt with heavy EtOH intake (>40g in females or >60g in males EtOH/day for >6 mos, or within <60 days of abstinence).
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul>
           <li style="list-style-type:none">
            <ul>
             <li style="list-style-type:none">
             </li>
            </ul>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="font-family:Palatino">
                  May present after they have quit drinking due to immunosuppressive effects of alcohol.
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="font-family:Palatino">
                  20-50% Mortality in hospitalized AH pts
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
        </ul>
        <p>
        </p>
        <p>
         <span style="page:WordSection1">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               Evaluation
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                AST >60, AST/ALT >1.5, both values <400 IU/L; TBili >3.0 mg/dL, documentation of heavy EtOH use until 8 weeks prior to presentation
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                Prognostication with Maddrey’s Discriminant Function: 4.6 * (PT
                <sub>
                 pt
                </sub>
                – PT
                <sub>
                 ctrl
                </sub>
                ) + Tbili
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul style="list-style-type:circle">
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="font-family:Palatino">
                  Maddrey
                 </span>
                </span>
                <u>
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   >
                  </span>
                 </span>
                </u>
                <span style="font-size:12.0pt">
                 <span style="font-family:Palatino">
                  32 = poor 30d prognosis & may benefit from steroids (see below)
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                RUQ to rule out obstructive cause of jaundice
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                Biopsy is not typically required but will show neutrophilic lobular inflammation, hepatocyte ballooning, steatosis, and pericellular fibrosis.
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                Phosphatidylethanol (PEth) level is a biomarker of ethanol consumption over ~ 4wks; >20 ng/mL can indicate chronic moderate/heavy alcohol intake
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul style="list-style-type:circle">
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="font-family:Palatino">
                  A single episode consumption can result in detectable Peth for up to 12 days. Can be elevated for months with regular heavy alcohol intake.
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="font-family:Palatino">
                  In some studies, 99% sensitive and specific for alcoholism.
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="font-family:Palatino">
                  EtOH levels may be negative unless acutely intoxicated
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
            <br/>
           </li>
          </ul>
         </li>
        </ul>
        <p>
         <span style="page:WordSection1">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               Management
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                Supportive Care is essential! Consult Nutrition, start High protein, high calorie diet, high dose Thiamine x 3d, Folate, MVI
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                Full infection workup (CXR, UA, BCx, paracentesis) regardless of sxs
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                Steroids:
               </span>
              </span>
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                STOP-AH Trial (NEJM 2015) showed improved mortality at 28 days but not at 90 days in patients with Maddrey
                <u>
                 >
                </u>
                32 who received steroids; the decision to treat is very nuanced and should be discussed with hepatology attending
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul>
           <li>
            <span style="font-size:11pt">
             <span style="line-height:normal">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 Contraindications to steroids include: presence of infection (must rule out first
                </span>
               </span>
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 including TB, uncontrolled GI bleeding, AKI w/ Cr >2.5 mg/dL)
                </span>
               </span>
              </span>
             </span>
            </span>
            ​​​​​​​
           </li>
           <li>
            <span style="font-size:11pt">
             <span style="line-height:normal">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 Prednisolone 40mg daily for pts who meet above criteria (2018 ACG Guidelines)
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="font-size:11pt">
             <span style="line-height:normal">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 The Lille score can be used to guide continuation or d/c  of steroids after 7 d of therapy
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="font-size:11pt">
             <span style="line-height:normal">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 NAC can be considered as adjunctive therapy to steroids and may decrease 30-day mortality, though has not demonstrated longer mortality benefit at 3 nor 6 months
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="font-size:11pt">
             <span style="line-height:normal">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 Recent analysis from STOP AH data has demonstrated that pts with neutrophil to lymphocyte ratio (NLR) 5-8 prior to steroids most likely to benefit from steroids
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
         <li>
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               Monitor on CIWA
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul>
           <li>
            <span style="font-size:11pt">
             <span style="line-height:normal">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 Psychiatry consultation as appropriate, consideration of medical therapy
                </span>
               </span>
              </span>
             </span>
            </span>
            <ul>
             <li>
              <span style="font-size:11pt">
               <span style="line-height:normal">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   Disulfiram and naltrexone are both metabolized by the liver and can cause hepatic toxicity and therefore are not used in this population
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </li>
             <li>
              <span style="font-size:11pt">
               <span style="line-height:normal">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   Baclofen has been shown to improve alcohol abstinence in pts with EtOH cirrhosis
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </li>
             <li>
              <span style="font-size:11pt">
               <span style="line-height:normal">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   Acamprosate has not been studied in this population but can be considered
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </li>
             <li>
              <span style="font-size:11pt">
               <span style="line-height:normal">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   Gabapentin has also demonstrated efficacy and can be given up to 1200mg for AUD
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </li>
            </ul>
           </li>
          </ul>
         </li>
        </ul>
       </div>
       <p style="margin-left:50px">
       </p>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="font-family:Palatino">
             Liver transplantation
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <ul>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              Current VUMC policy: pts should be abstinent for no less than 3-6 months, although exceptions may be made for early liver transplant based on a very strict protocol
             </span>
            </span>
           </span>
          </span>
         </span>
         <ul>
          <li>
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                Sustained Alcohol use post- Liver Transplant (SALT) score
               </span>
              </span>
              <span style="font-size:12.0pt">
               <span style='font-family:"Cambria Math",serif'>
                ≤
               </span>
              </span>
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                6
               </span>
              </span>
             </span>
            </span>
           </span>
           <ul>
            <li style="margin-left: 10px;">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="font-family:Palatino">
                  +4 points if >10 drinks/day at initial hospitalization
                 </span>
                </span>
               </span>
              </span>
             </span>
            </li>
            <li style="margin-left: 10px;">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="font-family:Palatino">
                  +4 points if multiple prior rehab attempts
                 </span>
                </span>
               </span>
              </span>
             </span>
            </li>
            <li style="margin-left: 10px;">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="font-family:Palatino">
                  +2 points if prior alcohol related legal issues
                 </span>
                </span>
               </span>
              </span>
             </span>
            </li>
            <li style="margin-left: 10px;">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="font-family:Calibri,sans-serif">
                <span style="font-size:12.0pt">
                 <span style="font-family:Palatino">
                  +1 points if prior illicit substance abuse
                 </span>
                </span>
               </span>
              </span>
             </span>
            </li>
           </ul>
          </li>
         </ul>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              “Exceptions:”
             </span>
            </span>
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              Severe AH as first liver-decompensating event in patients who are not expected to survive to complete treatment
             </span>
            </span>
           </span>
          </span>
         </span>
         <ul>
          <li style="margin-left: 10px;">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                Presence of strong sober social support
               </span>
              </span>
             </span>
            </span>
           </span>
          </li>
          <li style="margin-left: 10px;">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                Absence of severe uncontrolled coexisting psychiatric disorders
               </span>
              </span>
             </span>
            </span>
           </span>
          </li>
          <li style="margin-left: 10px;">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                Agreement by patient and family to adhere therapy and lifelong abstinence
               </span>
              </span>
             </span>
            </span>
           </span>
          </li>
         </ul>
        </li>
       </ul>
      </div>
     </div>
    </article>
   </div>
  </div>
 </body>
</html>